Atrial fibrillation in the Unit of Coronary Care
Keywords:
Atrial fibrillation, stroke, Oral administration.Abstract
Introduction: atrial fibrillation is the most frequent heart arrhythmia in the clinical practice; which is qualified as an epidemic that has important social repercussions.Objective: to characterize the atrial fibrillation in the Unit of Coronary Care at “Dr. Leon Cuervo Rubio” General Hospital in Pinar del Rio.
Material and Method: a descriptive and retrospective research was carried out from July 1, 2011 to July 1, 2012. The sample was comprised of the patients admitted suffering from atrial fibrillation.
Results: 70 year-old patients and older along with female sex prevailed with 63,3% and 61,2% respectively. Persistent clinical pattern was the most frequent found 38,7%, followed by paroxysmal type 30,6%; hypertension was the most frequent co-morbidity in more than 50%. Amiodarone was the most used therapeutic option in the patterns of the first episode, paroxysmal and persistent with 46,9%, classifying them as moderate risk (59,2%), followed by 24,5% of high risk; 100% of the patients presented high risk and underwent oral administration of anticoagulants, 96,5% of the patients were also classified as moderate risk.
Conclusions: ages from 70 and more and female sex prevailed; persistent clinical pattern was the most frequent along with hypertension as an associated morbidity. Amiodarone was the most used therapeutic option. Moderate risk prevailed and oral administration of anticoagulants was used in the majority of patients presenting moderate and/or high risks.
Downloads
References
1. Gersh BJ, Freedman JE, Granger ChG. Tratamiento antiagregante plaquetario y anticoagulante para la prevención del ictus en pacientes con fibrilación auricular no valvular: nuevos avances basados en la evidencia. Rev Esp Cardiol. [Internet] 2011 [Citado 20 de enero de 2012]; 64(4): [Aprox. 8p.]. Disponible en: http://www.revespcardiol.org/es/tratamiento-antiagregante-plaquetario-anticoagulante-prevencion/articulo/90002075/
2. Organización Mundial de la Salud. Estadísticas Sanitarias Mundiales 2010. OMS; 2010. Disponible en: http://www.who.int/gho/publications/world_health_statistics/2010/es/index.html [Citado 10 de julio de 2011]
3. Healey JS, Parkash R, Pollak T, Tsang T, Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. Can J Cardiol. [Internet] 2011 [Citado 10 de julio de 2011]; 27(1): [Aprox. 6p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0828282X10000164
4. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. [Internet] 2010 [Citado 10 de julio de 2011]; 303(4): [Aprox. 7p.]. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=185277
5. Banerjee A, Marín F, Lip GY. The improved but unfinished business of stroke risk stratification in atrial fibrillation. Rev Esp Cardiol. [Internet] 2011 [Citado 10 de julio de 2011]; 64(8): [Aprox. 2p.]. Disponible en: http://www.elsevier.es/es/revistas/revista-espa%C3%B1ola-cardiologia-25/avances-incompletos-estratificacion-riesgo-ictus-fibrilacion-auricular-90024415-editoriales-2011
6. Camm AJ. Guías de práctica clínica para el manejo de la fibrilación auricular. Rev Esp Cardiol. [Internet] 2010 [Citado 10 de julio de 2011]; 63(12): [Aprox. 16p.]. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13188310&pident_usuario=0&pcontactid
=&pident_revista=25&ty=106&accion=L&origen=cardio&web=http://www.revespcardiol.org&lan=es&fichero=25v63n12a13188310pdf001.pdf
7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. [Internet] 2010 [Citado 10 de julio de 2011]; 137(2): [Aprox. 9p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19762550
8. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation. The Framingham Heart Study. Circulation. [Internet]. 2004 [Citado 10 de julio de 2011]; 110(9): [Aprox. 4p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15313941
9. Pérez de Isla L, Avanzas P, Bayes-Genis A, Sanchis J, Heras M. Enfermedades sistémicas y corazón: introducción. Rev Esp Cardiol. [Internet]. 2011 [Citado 10 de julio de 2011]; 64(1): [Aprox. 1p.]. Disponible en: http://www.revespcardiol.org/es/enfermedades-sistemicas-corazon-introduccion/articulo/13190100/
10. Royo MA, Lobos JM, Millán J, Villar F, Brotons C, Camafort M, et al. En nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC). Med Clin (Barc). 2011; 137:30.e1-e13.
11. Masia R, Sala J, Marrugat J, Pena A. Prevalencia de fibrilación auricular en la provincia de Girona. El estudio REGICOR. Rev Esp Cardiol. [Internet]. 2001 [Citado 10 de julio de 2011]; 54(10): [Aprox. 4p.]. Disponible en: http://www.revespcardiol.org/es/prevalencia-fibrilacion-auricular-provincia-girona/articulo/13019378/
12. Gillis AM, Skanes AC. Comparing the 2010 North American and European atrial fibrillation guidelines. Can J Cardiol. [Internet]. 2011 [Citado 10 de julio de 2011]; 27(1): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21329856
13. Candel FJ, Matesanz M, Cogolludo F, Candel I, Mora C, Bescos T, et al. Prevalencia de fibrilación auricular y factores relacionados en una población del centro de Madrid. An Med Interna. [Internet]. 2004 [Citado 10 de julio de 2011]; 21(10): [Aprox. 5p.]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S0212-71992004001000003&script=sci_arttext
14. Benet M, Morejón A, Espinosa AD, Orlando O, Peraza D, Orduñez PO. Factores de riesgo para enfermedades crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II. Medisur. [Internet]. 2010 [Citado 10 de julio de 2011]; 8(2): [Aprox. 6p.]. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/1166
15. Nieuwlaat R, Capucci A, Camm J, Olsson B, Andresen D, Davies W, et al. Atrial fibrillation management: a prospective survey in ESC Member Countries. The EuroHeart Survey on Atrial Fibrillation. Eur Heart J. [Internet]. 2005 [Citado 10 de julio de 2011]; 26(22): [Aprox.12p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16204266
16. Peinado R, Arribas F, Ormaetxe JM, Badia X. Diferencias en la calidad de vida según el tipo de fibrilación auricular. Rev Esp Cardiol. [Internet]. 2010 [Citado 10 de julio de 2011]; 63(12): [Aprox. 7p.]. Disponible en: http://www.revespcardiol.org/es/diferencias-calidad-vida-segun-el/articulo/13188301/
17. Stiell IG, Macle L. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol. [Internet]. 2011 [Citado 10 de julio de 2011]; 27(1): [Aprox. 8p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21329861
18. Benito L, Hoyo J, Montroig A, Fornés B, Fluxá G, Martí D, et al. Estudio sobre los efectos adversos de los fármacos antiarrítmicos en pacientes con fibrilación auricular atendidos en un Centro de Atención Primaria. Med Clin (Barc). [Internet]. 2010 [Citado 10 de julio de 2011]; 137(6): [Aprox. 7p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0025775311003204
19. Ruiz M, Romo E, Mesa D, Delgado M, Anguita M, López A, et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol. [Internet]. 2011 [Citado 10 de julio de 2011]; 27(1): [Aprox. 16p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21329865
20. Ho LY, Siu CW, Yue WS, Lau CP, Lip GY, Tse HF. Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension. J Hum Hypertens. [Internet]. 2011 [Citado 10 de julio de 2011]; 25(5): [Aprox. 6p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20596062
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
